FIELD: biochemistry.
SUBSTANCE: invention relates to biochemistry. Invention describes oligonucleotides, modulating expression of hepatocyte growth factor (HGF), in particular, by means of targeted interaction with natural antisense polynucleotides of hepatocyte growth factor (HGF). Present invention also relates to the use of mentioned oligonucleotides for treating diseases and disorders, associated with HGF expression.
EFFECT: invention extends range of products for treating diseases and disorders, associated with HGF expression.
32 cl, 1 dwg, 2 ex
Authors
Dates
2017-02-02—Published
2010-12-23—Filed